Jim Tananbaum of Foresite Capital Welcomes Dr. Molly He

Recently, Foresite Capital Management announced DR. Molly He would be joining the company as a venture partner. Foresite is a venture capitalist firm that serves the healthcare market. As the company’s new appointment, Molly He, Ph.D. is expected to help create innovative medical solutions. Dr. He served at Illumina as a senior executive before she joined Foresite Capital. She has over 15 years of experience in pharmaceutical research as well as genomics. More details can be found on Ideamensch.

Foresite’s CEO, Dr. Jim Tananbaum, expressed his appreciation for Molly He’s expertise. He mentioned that Dr. He’s contribution to scientific studies is remarkable. Jim also added that Molly was considered for the partnership because of her leadership track record. He believes that her knowledge and experience would help Foresite Capital Management to expand their innovation portfolio.

At Illumina, Dr. Molly was responsible for the improvement of the company’s global protein reagent. She worked there for a few years before joining Pacific Biosciences. She was the head of protein sciences at Pacific and used her leadership position to help the firm develop their protein reagent. Her experience in creating protein reagents was one of the main reasons she was appointed as Foresite Capital’s venture partner.

He has also worked in the pharmaceutical industry for over a decade. She spent the earlier years of her career developing antibodies and solution that target cancer. Molly He got her Bachelor’s degree from Nankai University. She attended the University of California for her Doctorate. Dr. Molly has written over 20 papers. Her studies focus on next-generation sequencing and personal medicine. More details can be found on Forbes.

About Dr. Jim Tananbaum

Jim Tananbaum is the managing director and president of Foresight Capital. He founded the investment firm in 2010. Jim earned his Bachelor’s degree from the Yale University. According to his LinkedIn profile, he has a Master’s degree in Information Theory from MIT. Jim also holds an MBA from Harvard.

Over the years, Jim has worked hard to ensure that his company offers the best health care solutions. He believes in working with like-minded partners to achieve his business goals. Aside from Foresight, Jim has founded other companies, which include Prospect Venture Partners, GelTex, and Theravance. Check out his website officialjimtananbaum.com

 Click here: http://www.fiercebiotech.com/venture-capital/foresite-capital-reloads-a-450m-biotech-venture-fund

Leave a Reply

Your email address will not be published. Required fields are marked *